Group structure
4 companies in 2 countries
United Kingdom1
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Siiltibcy | Mycobacterium tuberculosis derived antigens | EU (EMA) | Authorised | 2025 |
| SIILTIBCYSoluzione iniettabile | Rdesat-6, Rcfp-10 | Italy | Authorised | |
| SIILTIBCY (0,5 microgram + 0,5 microgram)/ml oplossing voor injectie Mycobacterium tuberculosis afgeleide antigenen (rdESAT-6 en rCFP-10)Oplossing voor injectie | Recombinant cultuurfiltraateiwit van mycobacterium tuberculosis | Netherlands | Authorised | 2025 |
| SIILTIBCY (0,5 MICROGRAMOS + 0,5 MICROGRAMOS)/ML SOLUCION INYECTABLE0,5 microgramos/ml + 0,5 microgramos/ml · Solución inyectable | Rdesat-6, Rcfp-10 | Spain | Marketed | 2025 |
| MORU-VIRATEN BERNA VACCINE1 dose / kit + 1 dose / kit + .5 ml / kit · Liquid, Powder For Solution | Measles virus vaccine live attenuated, Rubella virus vaccine live attenuated, Water | Canada | Cancelled | 1996 |